Beta interferon and glatiramer acetate for the treatment of multiple sclerosis.
Contributors: National Health Service (Great Britain)
Series: Technical appraisal guidance -- no. 32
Publisher: National Institute for Clinical Excellence
Published: 2002
Place of publication: London
Language: eng
Number of pages: 22